Form 8-K - Current report:
SEC Accession No. 0001104659-25-021728
Filing Date
2025-03-07
Accepted
2025-03-07 16:05:31
Documents
16
Period of Report
2025-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm258554d1_8k.htm   iXBRL 8-K 42660
2 EXHIBIT 10.1 tm258554d1_ex10-1.htm EX-10.1 42457
3 EXHIBIT 10.2 tm258554d1_ex10-2.htm EX-10.2 36249
4 EXHIBIT 10.3 tm258554d1_ex10-3.htm EX-10.3 121579
  Complete submission text file 0001104659-25-021728.txt   466922

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA fwbi-20250303.xsd EX-101.SCH 3027
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE fwbi-20250303_lab.xml EX-101.LAB 34240
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fwbi-20250303_pre.xml EX-101.PRE 22367
18 EXTRACTED XBRL INSTANCE DOCUMENT tm258554d1_8k_htm.xml XML 3685
Mailing Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431
Business Address 777 YAMATO ROAD SUITE 502 BOCA RATON FL 33431 561-589-7020
Entero Therapeutics, Inc. (Filer) CIK: 0001604191 (see all company filings)

EIN.: 464993860 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37853 | Film No.: 25720011
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)